#Uveal

Alex Shoushtari, MD

alexshoushtari

Five years ago today, I started my first patient on a Phase 1 study for #uvealmelanoma. Today, we learned that it improves survival over single agent checkpoint blockade. Thanks @Immunocore

Bettina Ryll

BettinaRyll

Ok. Recently, I have been approached a lot to be involved as patient advocate in grant applications for cancer research projects. Let's call the entire experience *suboptimal*, so here are